Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Positive Study Results Published for KidneyIntelX

January 11, 2022
RNS Number : 1056Y Renalytix PLC 11 January 2022     Renalytix plc ("Renalytix" or the "Company")   Positive Study Results Published for KidneyIntelX TM in Monitoring Patient Response to New Drug Therapy   American Journal of Nephrology   data demonstrates KidneyIntelX successfully monitors patient

Partnership with Singing River for KidneyIntelX

January 10, 2022
RNS Number : 8490X Renalytix PLC 10 January 2022     Renalytix plc ("Renalytix" or the "Company")   Singing River Health System and Renalytix Join Forces to Improve Kidney Health   on the   Mississippi Gulf Coast Seventh KidneyIntelX implementation partnership for Renalytix focused on underserved

Appointment of Jean M. Casner as CHRO

January 7, 2022
RNS Number : 7098X Renalytix PLC 07 January 2022     Renalytix plc ("Renalytix" or the "Company")   Renalytix Appoints Jean M. Casner as Chief Human Resources Officer   NEW YORK, NY and SALT LAKE CITY, UT   January 7, 2022 - Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) today announced that Jean M.

RENX to present at 40th JP Morgan Healthcare Conf.

January 5, 2022
RNS Number : 4318X Renalytix PLC 05 January 2022     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Present at 40 th Annual J.P. Morgan Virtual Healthcare Conference   LONDON and SALT LAKE CITY , January 5, 2022 - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) today announced the Company

Joint program with American Diabetes Association

January 4, 2022
RNS Number : 2538X Renalytix PLC 04 January 2022   Renalytix plc ("Renalytix" or the "Company")   American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population   National program establishes early care management, technology innovation and large

Result of AGM

December 17, 2021
RNS Number : 0925W Renalytix PLC 17 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Result of AGM   LONDON and SALT LAKE , 17 December 2021   - Renalytix (NASDAQ: RNLX)  (LSE: RENX) announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were

Director/PDMR Shareholding

December 17, 2021
RNS Number : 0593W Renalytix PLC 17 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 17 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by Ann Berman , the Company's Non-Executive Director, of 3,000

Director/PDMR Shareholding

December 13, 2021
RNS Number : 3617V Renalytix PLC 13 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 13 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of

Director/PDMR Shareholding

December 9, 2021
RNS Number : 1070V Renalytix PLC 09 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 9 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase of 4,805 American Depositary Shares (" ADS ") by certain members of

Director/PDMR Shareholding

December 8, 2021
RNS Number : 9024U Renalytix PLC 08 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 8 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of 950
Displaying 1 - 10 of 183